Evaluation of a Brief, Scalable Module to Mitigate Suicidal Ideation Among Youth (Phase 2)
This project embeds the "Give to Others" (GO) talk therapy module in a standard, outpatient therapy protocol to demonstrate target engagement in the context of ongoing clinical care and testing the ability of the GO module to engage the target in a rigorous randomized controlled trial (RCT) of the intervention. We will target perceived burdensomeness (PB) among 80 clinic-referred youths (ages 12-17) who experience subacute suicidal ideation (SI; i.e., positive suicide risk screen; stable safety status).
Aperçu de l'étude
Statut
Les conditions
Description détaillée
Youths will be recruited from the FIU Center for Children and Families (CCF) waitlist and the community at large, and will be randomized to one of the following 2 arms: a 12-session talk therapy and suicide risk management condition (control arm); and a 12-session therapy and suicide risk management condition plus the GO module (active arm). We hypothesize that youths receiving the GO module will have lower levels of PB and burden-related interpretation bias at mid-treatment and post-treatment compared with youths who receive the control arm. We also hypothesize that youths receiving the GO module will have lower levels of PB and burden-related interpretation bias at midtreatment and posttreatment compared to pre-treatment levels.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Jeremy Pettit, PhD
- Numéro de téléphone: 305-348-1671
- E-mail: jpettit@fiu.edu
Sauvegarde des contacts de l'étude
- Nom: Victor Buitron, PhD
- Numéro de téléphone: 305-348-9880
- E-mail: vbuitron@fiu.edu
Lieux d'étude
-
-
Florida
-
Miami, Florida, États-Unis, 33199
- FIU Center for Children and Families
-
Chercheur principal:
- Victor Buitron, PhD
-
Contact:
- Jeremy Pettit, PhD
- Numéro de téléphone: 305-348-1671
- E-mail: jpettit@fiu.edu
-
Contact:
- Victor Buitron, PhD
- Numéro de téléphone: 305-348-9880
- E-mail: vbuitron@fiu.edu
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria
Adolescents must:
- be between ages 12 and 17 years
- score at or above the clinical cutoff on the Revised Child Anxiety and Depression Scale
- score at or above 4 on the Interpersonal Needs Questionnaire- Burdensomeness Scale
- have a positive screen for suicide risk (i.e., endorsement of suicidal ideation via self-report)
- be fluent in English and have available a parent who is fluent in English or Spanish
Exclusion Criteria
For adolescents to be excluded, they must:
- have cognitive impairment or developmental delay which does not allow for the completion of basic study procedures (i.e., reading and filling out questionnaires; talking to a clinician)
- show imminent risk or a history of hurting themselves or others requiring intensive and restrictive services
- be involved currently in a psychosocial treatment
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Seul
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: GO arm
Safety Planning + MATCH + GO module |
Safety planning is a standard suicide risk assessment and management protocol. This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction. The GO Module is a brief cognitive behavioral intervention targeting youth burden-related beliefs. It consists of one primary session and brief follow-up. The MATCH Anxiety and Depression modules involve a transdiagnostic protocol that adapts to individual clinical needs for teens experiencing internalizing symptoms. Participants receive weekly cognitive-behavioral therapy sessions guided by manualized decision flowcharts to sequence treatment strategies. |
|
Comparateur actif: Comparison Arm
Safety Planning + MATCH |
Safety planning is a standard suicide risk assessment and management protocol. This protocol involves determining level of risk based on current and prior suicidal thoughts and behavior, and then collaborative planning with youth and families for self-monitoring, self-regulation, help seeking, and suicide means restriction. The MATCH Anxiety and Depression modules involve a transdiagnostic protocol that adapts to individual clinical needs for teens experiencing internalizing symptoms. Participants receive weekly cognitive-behavioral therapy sessions guided by manualized decision flowcharts to sequence treatment strategies. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Self-report at Mid-treatment
Délai: From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
5-item youth self-ratings on perceived burdensomeness over the past week. Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35. Higher scores indicate higher levels of perceived burdensomeness (worse outcome). |
From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
|
Suicide Risk and Ideation Scale for Kids (S-RISK) - Child Report at Mid-Treatment
Délai: From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
The S-RISK measures the severity and intensity of suicidal thoughts and capability via 20 items. Higher scores indicate higher severity of suicide risk. |
From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Self-report at Post-treatment
Délai: From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
5-item youth self-ratings on perceived burdensomeness over the past week. Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35. Higher scores indicate higher levels of perceived burdensomeness (worse outcome). |
From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
|
Suicide Risk and Ideation Scale for Kids (S-RISK) - Child Report at Post-Treatment
Délai: From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
The S-RISK measures the severity and intensity of suicidal thoughts and capability via 20 items. Higher scores indicate higher severity of suicide risk. |
From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Parent report at Mid-Treatment
Délai: From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
5-item parent ratings on youth perceived burdensomeness over the past week. Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35. Higher scores indicate higher levels of perceived burdensomeness (worse outcome). |
From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
|
Sentence Completion Task- Liability Index at Mid-Treatment
Délai: From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
28-item youth completed task assessing burden-related interpretation bias. Participants read 28 sentences indicative of posing a liability on others and select negatively- or positively-valenced words to complete each sentence. Each item is scored 0 or 1, yielding a total score between 0 and 28. Higher scores indicate higher levels of burden interpretation bias (worse outcome). |
From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
|
Momentary Perceived Burdensomeness (mPB) Scale at Mid-Treatment
Délai: From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
The mPB scale was developed to capture real-time states of perceived burdensomeness (Lühr et al., 2026). mPB includes two self-report items rated 1 to 5 with higher scores indicating higher levels of burdensomeness. |
From pre-treatment to mid-treatment (within one week of completing the assigned intervention at the midpoint of CBT)
|
|
Interpersonal Needs Questionnaire- Burdensomenes Scale- Parent report at Post-Treatment
Délai: From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
5-item parent ratings on youth perceived burdensomeness over the past week. Each item is scored 1-7 (1 = not at all true for me; 7 = very true for me), yielding a total between 5 and 35. Higher scores indicate higher levels of perceived burdensomeness (worse outcome). |
From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
|
Sentence Completion Task- Liability Index at Post-Treatment
Délai: From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
28-item youth completed task assessing burden-related interpretation bias. Participants read 28 sentences indicative of posing a liability on others and select negatively- or positively-valenced words to complete each sentence. Each item is scored 0 or 1, yielding a total score between 0 and 28. Higher scores indicate higher levels of burden interpretation bias (worse outcome). |
From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
|
Momentary Perceived Burdensomeness (mPB) Scale at Post-Treatment
Délai: From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
The mPB scale was developed to capture real-time states of perceived burdensomeness (Lühr et al., 2026). mPB includes two self-report items rated 1 to 5 with higher scores indicating higher levels of burdensomeness. |
From pre-treatment to post-treatment (within one week of completing the final CBT session)
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Victor Buitron, PhD, Florida International University
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- IRB-26-0416
- R33MH137300 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
We will submit deidentified raw data to the National Institute of Mental Health (NIMH) Data Archive (NDA). The NDA is a data repository run by the NIMH that allows researchers studying mental health to collect and share deidentified information with each other. Our local data files will be coded, meaning we can track data back to subjects via a master key. However, we will upload de-identified electronic raw data collected from questionnaires and interviews to the NDA.
Délai de partage IPD
The scientific community will have access to data when the award ends. NDA will make decisions about how long to preserve the data, but that data archive has not deleted any deposited data up to now.
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .